Papers by Rosanna De Fina
Section 4: Clinical pharmacy services, 2021
Section 4: Clinical pharmacy services, 2021
Section 4: Clinical pharmacy services, 2021
patients with arrythmias. There is room for improvement, and the clinical pharmacist could collab... more patients with arrythmias. There is room for improvement, and the clinical pharmacist could collaborate in optimisation, improving the final results, and avoiding complications and drug related adverse effects. Creating a drug dispensing protocol in addition to a comprehensive clinical evaluation for antiarrhythmic therapy, taking all the risk factors, drug interactions and each patient's particular needs into consideration, is essential.
Bollettino SIFO, Jul 1, 2021
Bollettino SIFO, Nov 1, 2020
Bollettino SIFO, May 1, 2021
New treatment regimens for hepatitis C virus infection have radically changed the care of patient... more New treatment regimens for hepatitis C virus infection have radically changed the care of patients. Those that are recently commercialized, are subjected to intensive monitoring by AIFA with the aim to evaluate both the effectiveness and safety in clinical practice. The purpose of this retrospective observational study was the analysis of the incidence and severity of adverse reactions (ADRs) reported in the Region of Calabria regimens with antiviral agents Direct (DaaS), as well as evaluation of their effectiveness.
Uploads
Papers by Rosanna De Fina